Episode Outline:

Issues

      - Government through NIH grants provides money for investigators to find new drugs

      - PhRMA takes these findings and builds new drugs

      - Taxpayers don’t benefit from innovation, but pay high prices for drugs

      - Safe harbors for physicians and pharmacist who participates in studies

      - Safe harbor for physicians and pharmacist who participate in studies

PhRMA Issues

      - Development to production is costly

      - Research leads to many failures

      - Patent monopolies

      - Marketing is costly

Remember who benefits

      - Rare for counties to participate in profits of new drugs, either directly or indirectly

      - Universities profit from new drugs

      - Countries may provide tax incentives to help drug industry develop cheaper alternatives. 

_______

Make sure to subscribe to get the latest episode. 

Contact Us:

Email: [email protected]

Website: http://www.propharmaconsultants.com/

Facebook: https://www.facebook.com/propharmainc

Twitter: https://twitter.com/ProPharma

Instagram: https://www.instagram.com/propharmainc/

LinkedIn: https://www.linkedin.com/company/pro-pharma-pharmaceutical-consultants-inc/

Podcast: https://anchor.fm/pro-pharma-talks

YouTube: https://www.youtube.com/user/ProPharmaEducation